dihydropyridine calcium channel blockers (Univ Alberta)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedihydropyridine calcium channel blockers (Univ Alberta)
Drug Alias Name(+-)-BAY K 8644BAY-K-8644 analogs (University of Alberta)PN-202791
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channel
Therapy Area/IndicationsAngina PectorisHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alberta
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Alberta
Active IndicationsN/A
Inactive IndicationsAngina PectorisHeart Failure

Other Information

ATC CodeN/A
Related LinksN/A